about
Mitochondrial phosphate-carrier deficiency: a novel disorder of oxidative phosphorylationStructure and function of the BAH-containing domain of Orc1p in epigenetic silencingCharacterization and function in vivo of two novel phospholipases B/lysophospholipases from Saccharomyces cerevisiae.MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysisIdentification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma.Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation.AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis.Anaplastic large cell lymphoma arises in thymocytes and requires transient TCR expression for thymic egress.Novel therapeutic options in anaplastic large cell lymphoma: molecular targets and immunological tools.Novel treatment avenues for peripheral T-cell lymphomas.Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemia.STAT3 regulated ARF expression suppresses prostate cancer metastasis.p53-dependent non-coding RNA networks in chronic lymphocytic leukemia.JAK-STAT signaling in cancer: From cytokines to non-coding genome.Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma.Anaplastic large cell lymphoma-propagating cells are detectable by side population analysis and possess an expression profile reflective of a primitive origin.PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas.Antimyeloma activity of the sesquiterpene lactone cnicin: impact on Pim-2 kinase as a novel therapeutic target.Regulation of activity in vitro and in vivo of three phospholipases B from Saccharomyces cerevisiae.Interleukin-6 receptor alpha blockade improves skin lesions in a murine model of systemic lupus erythematosus.When the guardian sleeps: Reactivation of the p53 pathway in cancer.Stem cell hunt in NHL.Arsenic trioxide induces apoptosis preferentially in B-CLL cells of patients with unfavourable prognostic factors including del17p13.JunB and PTEN in prostate cancer: 'loss is nothing else than change'.Breaking a paradigm: IL-6/STAT3 signaling suppresses metastatic prostate cancer upon ARF expression.Insights into the Pathogenesis of Anaplastic Large-Cell Lymphoma through Genome-wide DNA Methylation Profiling.Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study.THE EFFECTS OF MIGRATORY FLIGHT ON HEMATOLOGIC PARAMETERS IN NORTHERN BALD IBISES ( GERONTICUS EREMITA).First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia.Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia.Anaplastic large cell lymphoma: the current state of play from a European prospective as presented at the second annual meeting of the European Research Initiative on ALCL, 27-28 June 2011.The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas.The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma.Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphomaActinomycin D induces p53-independent cell death and prolongs survival in high-risk chronic lymphocytic leukemiaAssessment of TP53 functionality in chronic lymphocytic leukaemia by different assays; an ERIC-wide approachErratum: STAT3 regulated ARF expression suppresses prostate cancer metastasisHepatic growth hormone - JAK2 - STAT5 signalling: Metabolic function, non-alcoholic fatty liver disease and hepatocellular carcinoma progressionThe role of essential pyrimidines in the hairpin ribozyme-catalysed reactionmicroRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia
P50
Q24680182-BB8FEA88-B953-4033-96A3-7CE9ADC14588Q27639534-430B53D0-1B38-47E2-9E8A-0B61710C77BDQ27936743-2809EBCF-DBE2-434B-8CA1-E85756E3198EQ30840070-EC247CC8-40F7-40C4-9CAE-20A7CA5885DFQ34136298-06D09D5F-47F4-4081-B29A-8FCFE6C912D6Q36018118-EF55A95A-5E98-4183-8E34-458A0C54866AQ36299786-AF0065D0-C3C5-431D-8B69-1797C1BDF39CQ36511310-ED2499B5-AA72-48A4-8392-3EBF23D6FC29Q37895417-88A87C88-2166-48F9-924B-31E23988B994Q38045460-1F15AEBD-B8DF-4543-B2E7-10C3FFFFC6C6Q38101382-7B2827CF-4061-43DE-9420-84AB996EC6F7Q38850627-8966C0FD-0FA4-4664-8870-34DC20A5D609Q38875344-5B854CD4-9341-42E6-9E00-750177E2D2D2Q38878851-B27FFEB3-8ADE-4282-9318-097B26A665D1Q38943591-A5C7701D-59AA-439A-A6EC-E43DAF9497BFQ38996543-1DD58369-0229-4D27-9A50-02AC56C55100Q39259618-5408AF51-215C-47DE-8DF6-7C7D05353686Q39421121-905C0CD0-C9B8-4354-8C85-73CDCC99B4CCQ41883055-C084C29B-96BB-47A2-A994-218DB6A9C09EQ41908236-C149C56E-B017-402D-A30F-622708192DC7Q41996415-1836EB00-31D0-460B-8BE6-EA42669C0B1AQ42122167-FB307BB6-EA16-46B3-B31C-DF6E4E3589C4Q42525060-3E05A397-BF01-4415-B240-48F0365E5FDCQ42558175-7FD118F1-6702-4573-8A1E-64435A406607Q42729905-BF7D961A-3201-4747-AA27-24D70D9606F4Q46530451-219B83C4-282C-480A-8CD2-2AE3ED286F7CQ47156715-CABFA3DF-537D-401F-921E-FB6429CFAB1AQ47214890-3B99DDBA-C8F9-4C71-A6CE-234CBBDA9F75Q47709885-16EA3968-5790-496B-A257-3F2276326F85Q49789839-7DF16561-07FD-4F23-A362-B853FFFA83BBQ51174486-1DD01834-FB0B-41E7-AD21-DEE846F34B4DQ52337767-5E308E09-C517-486C-B555-47035A41A55AQ52806518-EE6A9A6A-509E-4E32-AAD1-DA0C9112C27FQ57174069-259C4573-1E17-4825-9651-26DF06812AC7Q57229768-EBE83142-2B17-43CA-ADCE-7E49290E0127Q58041691-C3CB77D9-9809-4856-9A36-1E875D41FE93Q58455449-D7DF95EB-4E48-45C3-8B87-6E0C23699CBEQ58590738-00A3B254-5CD0-4440-87EB-ADB51E993603Q77753761-0A542591-95B1-4F5A-842A-B830B83ECCFFQ82589392-5B8BFEAE-6D91-46F8-A47F-9E86AC23CBB7
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Olaf Merkel
@ast
Olaf Merkel
@en
Olaf Merkel
@es
Olaf Merkel
@nl
Olaf Merkel
@sl
أولاف ميركل
@ar
type
label
Olaf Merkel
@ast
Olaf Merkel
@en
Olaf Merkel
@es
Olaf Merkel
@nl
Olaf Merkel
@sl
أولاف ميركل
@ar
prefLabel
Olaf Merkel
@ast
Olaf Merkel
@en
Olaf Merkel
@es
Olaf Merkel
@nl
Olaf Merkel
@sl
أولاف ميركل
@ar
P106
P1153
7801579995
P31
P496
0000-0001-5089-344X